查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2024187

全球臨床實驗室服務市場：策略與趨勢，包括按檢測類型、地點、產品和國家分類的預測—高階主管和顧問的指導性情境分析（2026-2030 年）—第 9 版

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides - 9th Edition. 2026 to 2030
出版日期: | 出版商: Howe Sound Research | 英文 385 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

報告摘要：

臨床實驗室服務是現代醫學的基礎組成部分，提供用於疾病檢測、治療方案製定和患者健康監測的診斷資訊。臨床實驗室支持多種疾病的診療，包括心血管疾病、糖尿病、感染疾病、傳染病、自體免疫、腎臟疾病和代謝性疾病。臨床實驗室服務涵蓋廣泛的檢測類別，包括臨床化學、血液學、免疫檢測、微生物學、分子診斷、基因檢測、毒理學和組織病理學。

全球臨床實驗室服務市場預計到 2025 年將達到 2,031 億美元，並預計以 8.8% 的複合年成長率成長，到 2030 年達到 3,102 億美元。這一成長是由人口老化、慢性病患病率上升、醫療保健服務覆蓋範圍擴大以及對預防醫學和疾病早期檢測的日益重視等人口趨勢所驅動的。

臨床實驗室檢測在醫療決策中發揮著至關重要的作用。臨床檢測結果常用於確診、評估疾病進展、評估治療效果、監測病人安全。隨著醫療體係日益重視實證醫學，對臨床實驗室服務的需求也持續成長。

臨床實驗室服務範圍

臨床檢測服務涵蓋多種檢測類別。

臨床化學檢測透過測量血液和其他體液中生物標記的濃度來評估器官功能和代謝狀態。例如，血糖檢測、血脂檢測、肝功能檢測、腎功能檢測和電解質測定等。

血液學檢查評估血球和凝血參數。血液常規檢查（CBC）是臨床上最常進行的檢查之一。

免疫檢測利用抗原-抗體結合反應來檢測蛋白質、荷爾蒙、抗體和其他分析物。免疫檢測廣泛應用於內分泌學、傳染病檢查和癌症生物標記分析。

微生物檢測採用培養法、抗原檢測法和分子技術來檢測細菌、病毒、真菌和寄生蟲等病原體。

分子診斷技術能夠透過檢測與疾病相關的核酸序列，以高靈敏度檢測感染疾病和遺傳異常。

基因檢測評估與疾病風險和治療反應相關的基因變異。

組織病理學是檢查組織檢體以診斷癌症和其他疾病的領域。

毒理學檢測可以檢測出毒品、環境毒素和其他物質。

市場結構

臨床實驗室服務由各種機構提供，包括醫院檢查室、獨立實驗室、診所檢查室、大學醫院和公共衛生實驗室。

醫院檢查室進行各項檢測，以支持住院和門診病人的臨床治療。許多醫院也向診所和其他醫療機構提供推廣檢測服務。

獨立實驗室通常會收到來自眾多醫療保健機構的大量檢測請求，並運作集中式檢測設施，由物流網路支援檢體運輸。

診所內檢查室在診所內進行常規檢測。

公共衛生檢查室進行與疾病監測和集體爆發監測相關的檢測。

在許多情況下，檢測實驗室提供廣泛的檢測項目和專業的檢測能力。

檢測網路通常運作多個檢測設施，以確保地理覆蓋範圍並最佳化報告檢測結果所需的時間。

市場促進因素

推動臨床實驗室服務市場成長的因素有很多。

隨著人口老化，糖尿病、心血管疾病和癌症等慢性疾病的盛行率不斷上升，促使對診斷測試的需求增加。

預防性醫療保健服務的日益普及，也帶動了對常規臨床檢測的需求。

隨著個人化醫療的擴展，分子診斷和基因檢測等專業臨床檢測的使用正在增加。

隨著慢性病盛行率的增加，對持續病患監測的需求也日益成長。

診斷技術的進步使得開發新的臨床檢測方法成為可能。

新興市場醫療保健服務的改善促進了檢測數量的增加。

臨床指引越來越推薦使用臨床檢測來進行疾病管理。

許多地區擴大醫療保險覆蓋範圍，提高了獲得臨床實驗室服務的機會。

科技趨勢

技術創新提高了臨床檢查室的效率，並擴大了它們可以進行的檢測範圍。

檢體處理和分析工作流程的自動化提高了處理能力，並縮短了報告結果的時間。

分子診斷技術正在擴大可透過臨床檢測診斷的疾病範圍。

數位病理技術實現了組織檢體的遠端分析，加強了病理學家之間的合作。

實驗室資訊系統改善了實驗室數據的管理及其與電子健康記錄的整合。

即時檢測技術正在擴大傳統檢查室環境以外的診斷檢測途徑。

人工智慧工具正在被開發出來，以輔助解讀診斷結果。

自動化減少了人工操作流程，提高了可重複性。

機器人技術和先進設備的整合提高了檢查室效率。

市場區隔

臨床實驗室服務市場可以按檢測類型、服務提供者、最終用戶和地區進行細分。

按檢測類型分類，臨床化學和血液學檢測佔了檢測量最大的部分。由於精準醫療方法的日益普及，分子診斷和基因檢測正迅速成為成長最快的領域。

按服務供應商，醫院檢查室和獨立實驗室構成主要部分。

最終使用者包括醫院、診所、門診部和公共衛生組織。

由於北美地區醫療費用支出高、診斷基礎設施先進，因此是最大的區域市場。

歐洲擁有完善的醫療保健體系，是重要的市場。

由於對醫療基礎設施的投資增加，亞太市場正在擴張。

在新興市場，隨著診斷服務可近性的提高，潛在的成長機會正在湧現。

競爭格局

臨床實驗室服務市場包括大規模全國性檢測網路、區域實驗室、醫院檢查室和專業診斷服務供應商。

競爭的促進因素包括價格、檢測結果報告時間、地理覆蓋範圍以及可用檢測的廣度。

大規模測試網路可以受益於規模經濟和集中式測試設施。

檢測實驗室與醫療保健提供者之間的策略夥伴關係可以影響市場佔有率。

整合先進的診斷技術可以提供競爭優勢。

選擇檢測實驗室時，服務品質和可靠性是重要的考慮因素。

物流能力在檢體運輸中扮演至關重要的角色。

檢測實驗室正加大對數位基礎設施和自動化技術的投資。

未來展望

隨著診斷檢測需求的成長，臨床實驗室服務市場預計將繼續擴張。

分子診斷和基因檢測的發展可能會擴大檢測服務在個人化醫療中的作用。

自動化技術可以提高效率，並有可能降低每次檢測的成本。

擴大即時檢測範圍可作為集中檢測服務的補充。

人工智慧（AI）工具可以提高對測試數據的解讀能力。

人口健康管理措施可能會促使預防醫學中檢測手段的增加。

總體而言，臨床實驗室服務是醫療保健服務的重要組成部分。診斷技術、自動化和數據分析的不斷進步有望支撐市場長期穩定成長。

目錄

第1章 市集指南

  • 戰略態勢分析
    • 在醫療保健服務中的作用
    • 價格壓力和贖回限制
    • 市場整合與競爭格局
    • 勞動力短缺和營運挑戰
    • 技術創新與數位轉型
    • 分子和基因檢測的擴展
    • 監管和品質要求
    • 物流和樣品管理方面的挑戰
    • 地理市場動態
    • 展望與戰略意義
  • 企業主管、行銷負責人、銷售負責人和業務拓展負責人。
  • 管理顧問和投資顧問指南
  • 人工智慧的影響

第2章：引言與市場定義

  • 對臨床試驗的新需求
  • 機會的定義
  • 調查方法
  • 展望：醫療保健和體外診斷產業

第3章：動態市場概述

  • 參與企業充滿活力的市場
    • 學術研究辦公室
    • 診斷測試開發人員
    • 測量儀器供應商
    • 化學品/試劑供應商
    • 病理檢測用品供應商
    • 獨立臨床實驗室
    • 國家/地區公共研究機構
    • 醫院檢查室
    • 醫師診所檢查室(POLS)
    • 審計機構
    • 認證機構
  • 細分——多種方法
  • 臨床檢測產業的結構
  • 國家和地區的多樣性

第4章：推動市場變化的趨勢

  • 成長的驅動力來自多個方面。
  • 促使市場萎縮的因素
  • 自動化和實驗室的發展趨勢

第5章：臨床實驗室服務的最新趨勢

第6章：主要企業概況

  • Accel Diagnostics
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • Aegis Science Corporation
  • American Bio-Clinical Laboratories, Int'l
  • ARUP Laboratories
  • Ascend Clinical
  • Bio-Reference Laboratories
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • C2N Diagnostics
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • DASA
  • DIAN Diagnostics Co., Ltd.
  • Enzo Biochem
  • Eone Laboratories
  • Eurofins Scientific
  • Exagen Diagnostics
  • Flow Health
  • Fyr Diagnostics
  • Genzyme Corporation
  • Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • Haystack Oncology（Quest Dx）
  • Innoquest Pathology
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs（Quest）
  • Mayo Clinic Laboratories
  • Medicover
  • Myriad Genetics
  • NeoGenomics
  • OncoDNA
  • Oncohost
  • Prometheus Laboratories
  • ProPhase Labs
  • Psychemedics Corporation
  • Quest Diagnostics
  • SkylineDx
  • Sonic Healthcare
  • Sophia Genetics
  • Spectra Laboratories
  • Streamline Scientific
  • Synlab
  • -Sysmex Inostics
  • Unilabs
  • Werfen

第7章：全球臨床檢測市場

  • 全球市場概覽（按國家/地區分類）
  • 全球市場概覽（按檢測類型分類）
  • 全球市場概覽（按地區分類）
  • 全球市場概覽（按產品分類）

第8章 全球臨床實驗室診斷市場－依檢測類型分類

  • 化學
  • 微生物學
  • 血液學
  • 解剖病理學
  • 分子診斷
  • 神秘測試

第9章 全球臨床實驗室診斷市場－按地區分類

  • 住院醫院
  • 門診病人醫院
  • 獨立研究機構
  • 臨床檢查室
  • 其他

第10章：全球臨床實驗室診斷市場－依產品分類

  • 裝置
  • 試劑
  • 人事費用
  • 間接費用
  • 其他

第11章：臨床檢查室的未來

第12章附錄

表格一覽

圖表清單

簡介目錄
Product Code: CLIN 426

Report Overview:

Clinical laboratory testing services represent a foundational component of modern healthcare, providing diagnostic information used to detect disease, guide treatment decisions, and monitor patient health. Laboratory testing supports management of a wide range of medical conditions including cardiovascular disease, diabetes, cancer, infectious diseases, autoimmune disorders, kidney disease, and metabolic conditions. Clinical laboratory services include a broad array of test categories such as clinical chemistry, hematology, immunoassays, microbiology, molecular diagnostics, genetic testing, toxicology, and anatomic pathology.

The global Clinical Laboratory Testing Services market is estimated to be USD 203.1 billion in 2025 and is expected to grow at compound annual growth rates of 8.8% through to 2030 when it will reach USD 310.2 Billion. Growth is driven by demographic trends including aging populations, increasing prevalence of chronic diseases, expanding access to healthcare services, and growing emphasis on preventive medicine and early disease detection.

Laboratory testing plays an important role in healthcare decision-making. Clinical laboratory results are frequently used to confirm diagnoses, evaluate disease progression, assess treatment effectiveness, and monitor patient safety. As healthcare systems increasingly emphasize evidence-based medicine, demand for laboratory testing services continues to increase.

Scope of Laboratory Testing Services

Clinical laboratory services encompass a wide range of testing categories.

Clinical chemistry tests measure levels of biomarkers in blood and other body fluids to evaluate organ function and metabolic health. Examples include glucose testing, lipid panels, liver function tests, kidney function tests, and electrolyte measurements.

Hematology tests evaluate blood cells and coagulation parameters. Complete blood count (CBC) tests represent one of the most commonly ordered laboratory tests.

Immunoassays detect proteins, hormones, antibodies, and other analytes using antigen-antibody binding reactions. Immunoassay testing is widely used in endocrinology, infectious disease testing, and cancer biomarker analysis.

Microbiology testing detects bacterial, viral, fungal, and parasitic pathogens using culture methods, antigen detection, and molecular techniques.

Molecular diagnostics detect nucleic acid sequences associated with disease, enabling highly sensitive detection of infectious diseases and genetic abnormalities.

Genetic testing evaluates inherited variations associated with disease risk or treatment response.

Anatomic pathology involves examination of tissue samples to diagnose cancer and other diseases.

Toxicology testing detects drugs, environmental toxins, and other substances.

Market Structure

Clinical laboratory testing services are delivered through multiple types of providers including hospital-based laboratories, independent reference laboratories, physician office laboratories, academic medical centers, and public health laboratories.

Hospital laboratories perform testing to support inpatient and outpatient clinical care. Many hospitals also provide outreach testing services to physician offices and other healthcare providers.

Independent reference laboratories perform large volumes of testing from multiple healthcare providers and often operate centralized testing facilities supported by logistics networks for specimen transport.

Physician office laboratories perform routine tests within medical practices.

Public health laboratories perform testing related to disease surveillance and outbreak monitoring.

Reference laboratories often offer extensive test menus and specialized testing capabilities.

Laboratory networks often operate multiple testing facilities to support geographic coverage and optimize turnaround time.

Market Drivers

Several factors are driving growth in the clinical laboratory testing services market.

Aging populations are increasing demand for diagnostic testing due to higher prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer.

Increasing use of preventive healthcare services is supporting demand for routine laboratory testing.

Expansion of personalized medicine is increasing use of specialized laboratory tests such as molecular diagnostics and genetic testing.

Growth in chronic disease prevalence is increasing demand for ongoing patient monitoring.

Advances in diagnostic technologies are enabling development of new laboratory tests.

Increased healthcare access in emerging markets is supporting growth in testing volumes.

Clinical guidelines increasingly recommend laboratory testing for disease management.

Expansion of health insurance coverage in many regions supports access to laboratory services.

Technology Trends

Technological innovation is improving efficiency and expanding test menus within clinical laboratories.

Automation of sample processing and analytical workflows is improving throughput and reducing turnaround time.

Molecular diagnostics technologies are expanding the range of conditions that can be diagnosed using laboratory testing.

Digital pathology technologies enable remote analysis of tissue samples and improved collaboration among pathologists.

Laboratory information systems improve management of test data and integration with electronic health records.

Point-of-care testing technologies are expanding access to diagnostic testing outside traditional laboratory settings.

Artificial intelligence tools are being developed to assist interpretation of diagnostic results.

Automation is reducing manual processing steps and improving reproducibility.

Integration of robotics and advanced instrumentation is improving laboratory efficiency.

Market Segmentation

The clinical laboratory testing services market can be segmented by test type, service provider, end user, and geographic region.

By test type, clinical chemistry and hematology represent high-volume segments. Molecular diagnostics and genetic testing represent rapidly growing segments due to increasing use of precision medicine approaches.

By service provider, hospital laboratories and independent reference laboratories represent major segments.

End users include hospitals, physician offices, outpatient clinics, and public health agencies.

North America represents the largest regional market due to high healthcare spending and advanced diagnostic infrastructure.

Europe represents a significant market supported by established healthcare systems.

Asia-Pacific markets are expanding due to increasing investment in healthcare infrastructure.

Emerging markets represent potential growth opportunities as access to diagnostic services improves.

Competitive Landscape

The clinical laboratory testing services market includes large national laboratory networks, regional laboratories, hospital laboratories, and specialized diagnostic service providers.

Competition is influenced by pricing, turnaround time, geographic coverage, and breadth of test menu.

Large laboratory networks may benefit from economies of scale and centralized testing facilities.

Strategic partnerships between laboratories and healthcare providers may influence market share.

Integration of advanced diagnostic technologies may provide competitive advantages.

Service quality and reliability are important factors in laboratory selection.

Logistics capabilities play an important role in specimen transport.

Laboratories are increasingly investing in digital infrastructure and automation technologies.

Future Outlook

The clinical laboratory testing services market is expected to continue expanding as demand for diagnostic testing increases.

Growth in molecular diagnostics and genetic testing may expand the role of laboratory services in personalized medicine.

Automation technologies may improve efficiency and reduce cost per test.

Expansion of point-of-care testing may complement centralized laboratory services.

Artificial intelligence tools may improve interpretation of laboratory data.

Population health management initiatives may increase use of laboratory testing for preventive care.

Overall, clinical laboratory testing services represent a critical component of healthcare delivery. Continued advances in diagnostic technologies, automation, and data analytics are expected to support steady long-term market growth.

Table of Contents

1 Market Guides

  • 1.1 Strategic Situation Analysis
    • 1.1.1 Role in Healthcare Delivery
    • 1.1.2 Pricing Pressure and Reimbursement Constraints
    • 1.1.3 Market Consolidation and Competitive Landscape
    • 1.1.4 Workforce Shortages and Operational Challenges
    • 1.1.5 Technological Innovation and Digital Transformation
    • 1.1.6 Expansion of Molecular and Genetic Testing
    • 1.1.7 Regulatory and Quality Requirements
    • 1.1.8 Logistics and Sample Management Challenges
    • 1.1.9 Geographic Market Dynamics
    • 1.1.10 Outlook and Strategic Implications
  • 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3 Guide for Management Consultants and Investment Advisors
  • 1.4 Impact of Artificial Intelligence

2 Introduction and Market Definition

  • 2.1 The New Demand for Clinical Testing
  • 2.2 Defining the Opportunity
    • 2.2.1 Revenue Market Size
  • 2.3 Methodology
    • 2.3.1 Methodology
    • 2.3.2 Sources
    • 2.3.3 Authors
  • 2.4 Perspective: Healthcare and the IVD Industry
    • 2.4.1 Global Healthcare Spending
    • 2.4.2 Spending on Diagnostics
    • 2.4.3 Important Role of Insurance for Diagnostics

3 Overview of a Dynamic Market

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Instrumentation Supplier
    • 3.1.4 Chemical/Reagent Supplier
    • 3.1.5 Pathology Supplier
    • 3.1.6 Independent Clinical Laboratory
    • 3.1.7 Public National/regional Laboratory
    • 3.1.8 Hospital Laboratory
    • 3.1.9 Physicians Office Lab (POLS)
    • 3.1.10 Audit Body
    • 3.1.11 Certification Body
  • 3.2 Segmentation - Different Approaches
    • 3.2.1 Traditional Market Segmentation
    • 3.2.2 Laboratory Focus and Segmentation
  • 3.3 Structure of Clinical Testing Industry
    • 3.3.1 The Hospital Lab - Share of the Pie
    • 3.3.2 Key Role for Economies of Scale
    • 3.3.3 Physician Office Lab's are Still Here
    • 3.3.4 Physician's and POCT - Reviving Patient Service in China
  • 3.4 National and Regional Diversity

4 Trends Driving a Changing Market

  • 4.1 Growth Is Pushed from Many Sides
    • 4.1.1 Demographic Impacts on Consumption
    • 4.1.2 COVID Related Impacts
    • 4.1.3 Point of Care Testing Makes a Difference
    • 4.1.4 Alternative Medicine Effect
    • 4.1.5 Esoterics
    • 4.1.6 A New Laboratory Discipline
  • 4.2 Factors at Work to Shrink the Market
    • 4.2.1 Where are Costs Going?
    • 4.2.2 Population Effects
    • 4.2.3 Management Practices
    • 4.2.4 Wellness
    • 4.2.5 Cannabilization
    • 4.2.6 Point of Care
  • 4.3 Automation and Laboratory Trends
    • 4.3.1 Traditional Automation and Centralization
    • 4.3.2 The New Automation, Decentralization and Point Of Care
    • 4.3.3 Instruments Key to Market Share
    • 4.3.4 Bioinformatics Plays a Role
    • 4.3.5 PCR Takes Command
    • 4.3.6 Next Generation Sequencing Fuels a Revolution
    • 4.3.7 NGS Impact on Pricing
    • 4.3.8 Whole Genome Sequencing, A Brave New World
    • 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10 Shifting Role of Diagnostics

5 Clinical Laboratory Services Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
  • 5.2 Source Bioscience Acquires Cambridge Clinical Labs
  • 5.3 Labcorp Acquires Select Assets of BioReference Health
  • 5.4 hc1 + Accumen Launches Clinical Excellence Solutions
  • 5.5 Labcorp enters lab management, services agreement with Inspira Health
  • 5.6 Aventa Genomics Receives Favorable Pricing Determination
  • 5.7 Perseus Completes Acquisition of Matrix Sistemas e Servicos Ltda
  • 5.8 Delve Bio Announces Partnership with Broad Clinical Labs for mNGS
  • 5.9 Quest Dx to Acquire Select Lab Assets from Allina Health
  • 5.10 Eurofins buys Ascend Clinical LLC
  • 5.11 Atalan Sees Potential in Hospital Outreach Business
  • 5.12 Challenge Bringing Routine Testing to Point of Care
  • 5.13 Natera Cites Test Volume Growth, Rosy Reimbursement
  • 5.14 Patients Becoming Stakeholders in Infectious Disease Testing
  • 5.15 MedGenome Acquires Prognosis Laboratories
  • 5.16 Brooks Automation acquires Aim Lab
  • 5.17 Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
  • 5.18 Mayo Clinic Laboratories and Helix to provide Biopharma Services
  • 5.19 CompuGroup Medical acquires Medicus Laboratory Information Systems
  • 5.20 Quest Diagnostics acquires Summa Health outreach lab
  • 5.21 Q2 Solutions Launches Self-Collection Safety Lab Panel
  • 5.22 Bionano Genomics Announces Launch of Bionano Laboratories
  • 5.23 Labcorp to Spin Off Clinical Development Business
  • 5.24 Value-Based Care Growing More Profitable for Labs
  • 5.25 Lucid Diagnostics Reports Revenue Growth
  • 5.26 NGS Cancer Testing Decision Appeases Industry
  • 5.27 Clinical Labs Make Strong Showing in 2021
  • 5.28 Seegene to Enter Syndromic MDx Space
  • 5.29 EKF Diagnostics Acquires Advanced Diagnostic Laboratory
  • 5.30 Molecular Health, EDGC Ink Liquid Biopsy Partnership
  • 5.31 ProPhase Labs Acquires Nebula Genomics for $14.6M
  • 5.32 Karius Cell-Free DNA Method to Detect Infection Validated
  • 5.33 EDGC Enters Liquid Biopsy Space With Cf DNA
  • 5.34 TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
  • 5.35 Enzo Biochem Q2 Revenues Up 62 Percent
  • 5.36 Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • 5.37 FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • 5.38 Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • 5.39 Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
  • 5.40 Cooperative Aims to Expand Clinical, Commercial NGS Access

6 Profiles of Key Companies

  • 6.1 Accel Diagnostics
  • 6.2 Acibadem Labmed Laboratory
  • 6.3 ACM Medical Laboratory
  • 6.4 Adicon Clinical Laboratories
  • 6.5 Aegis Science Corporation
  • 6.6 American Bio-Clinical Laboratories, Int'l
  • 6.7 ARUP Laboratories
  • 6.8 Ascend Clinical
  • 6.9 Bio-Reference Laboratories
  • 6.10 Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 6.11 BP Healthcare Group
  • 6.12 C2N Diagnostics
  • 6.13 Clinical Reference Laboratory
  • 6.14 Clongen Laboratories
  • 6.15 CompuNet Clinical Laboratories
  • 6.16 DASA
  • 6.17 DIAN Diagnostics Co., Ltd.
  • 6.18 Enzo Biochem
  • 6.19 Eone Laboratories
  • 6.20 Eurofins Scientific
  • 6.21 Exagen Diagnostics
  • 6.22 Flow Health
  • 6.23 Fyr Diagnostics
  • 6.24 Genzyme Corporation
  • 6.25 Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • 6.26 Haystack Oncology (Quest Dx)
  • 6.27 Innoquest Pathology
  • 6.28 Integrated Regional Laboratories
  • 6.29 KDL Group
  • 6.30 Laboratory Corporation of America
  • 6.31 Lifelabs (Quest)
  • 6.32 Mayo Clinic Laboratories
  • 6.33 Medicover
  • 6.34 Myriad Genetics
  • 6.35 NeoGenomics
  • 6.36 OncoDNA
  • 6.37 Oncohost
  • 6.38 Prometheus Laboratories
  • 6.39 ProPhase Labs
  • 6.40 Psychemedics Corporation
  • 6.41 Quest Diagnostics
  • 6.42 SkylineDx
  • 6.43 Sonic Healthcare
  • 6.44 Sophia Genetics
  • 6.45 Spectra Laboratories
  • 6.46 Streamline Scientific
  • 6.47 Synlab
  • 6.48 -Sysmex Inostics
  • 6.49 Unilabs
  • 6.50 Werfen

7 The Global Market for Clinical Laboratory Testing

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country
  • 7.2 Global Market by Assay Type - Overview
    • 7.2.1 Table - Global Market by Assay Type
    • 7.2.2 Chart - Global Market by Assay Type - Base/Final Year Comparison
    • 7.2.3 Chart - Global Market by Assay Type - Base Year
    • 7.2.4 Chart - Global Market by Assay Type - End Year
    • 7.2.5 Chart - Global Market by Assay Type - Share by Year
    • 7.2.6 Chart - Global Market by Assay Type - Segments Growth
  • 7.3 Global Market by Place - Overview
    • 7.3.1 Table - Global Market by Place
    • 7.3.2 Chart - Global Market by Place - Base/Final Year Comparison
    • 7.3.3 Chart - Global Market by Place - Base Year
    • 7.3.4 Chart - Global Market by Place - End Year
    • 7.3.5 Chart - Global Market by Place - Share by Year
    • 7.3.6 Chart - Global Market by Place - Segments Growth
  • 7.4 Global Market by Product - Overview
    • 7.4.1 Table - Global Market by Product
    • 7.4.2 Chart - Global Market by Product - Base/Final Year Comparison
    • 7.4.3 Chart - Global Market by Product - Base Year
    • 7.4.4 Chart - Global Market by Product - End Year
    • 7.4.5 Chart - Global Market by Product - Share by Year
    • 7.4.6 Chart - Global Market by Product - Segments Growth

8 Global Clinical Laboratory Diagnostic Markets - By Assay Type

  • 8.1 Chemistry
    • 8.1.1 Table Chemistry - by Country
    • 8.1.2 Chart - Chemistry Growth
  • 8.2 Microbiology
    • 8.2.1 Table Microbiology - by Country
    • 8.2.2 Chart - Microbiology Growth
  • 8.3 Hematology
    • 8.3.1 Table Hematology - by Country
    • 8.3.2 Chart - Hematology Growth
  • 8.4 Anatomic Pathology
    • 8.4.1 Table Anatomic Pathology - by Country
    • 8.4.2 Chart - Anatomic Pathology Growth
  • 8.5 Molecular Diagnostics
    • 8.5.1 Table Molecular Diagnostics - by Country
    • 8.5.2 Chart - Molecular Diagnostics Growth
  • 8.6 Esoteric
    • 8.6.1 Table Esoteric - by Country
    • 8.6.2 Chart - Esoteric Growth

9 Global Clinical Laboratory Diagnostic Markets - By Place

  • 9.1 In Patient Hospital
    • 9.1.1 Table In Patient Hospital - by Country
    • 9.1.2 Chart - In Patient Hospital Growth
  • 9.2 Out Patient Hospital
    • 9.2.1 Table Out Patient Hospital - by Country
    • 9.2.2 Chart - Out Patient Hospital Growth
  • 9.3 Independent Laboratory
    • 9.3.1 Table Independent Laboratory - by Country
    • 9.3.2 Chart - Independent Laboratory Growth
  • 9.4 Physicians Office Laboratory
    • 9.4.1 Table Physicians Office Laboratory - by Country
    • 9.4.2 Chart - Physicians Office Laboratory Growth
  • 9.5 Other Laboratory
    • 9.5.1 Table Other Laboratory - by Country
    • 9.5.2 Chart - Other Laboratory Growth

10 Global Clinical Laboratory Diagnostic Markets - By Product

  • 10.1 Instruments
    • 10.1.1 Table Instruments - by Country
    • 10.1.2 Chart - Instruments Growth
  • 10.2 Reagents
    • 10.2.1 Table Reagents - by Country
    • 10.2.2 Chart - Reagents Growth
  • 10.3 Labour
    • 10.3.1 Table Labour - by Country
    • 10.3.2 Chart - Labour Growth
  • 10.4 Overhead
    • 10.4.1 Table Overhead - by Country
    • 10.4.2 Chart - Overhead Growth
  • 10.5 Other Product
    • 10.5.1 Table Other Product - by Country
    • 10.5.2 Chart - Other Product Growth

11 The Future of the Clinical Laboratory

12 Appendices

  • 12.1 United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2 The Most Used IVD Assays
  • 12.3 The Highest Grossing Assays

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Clinical Laboratory Departments and Segments
  • Table 3 Laboratory Management Focus - Different Approaches
  • Table 4 Key Segmentation Variables Going Forward
  • Table 5 Factors Affecting Local Clinical Testing Demand
  • Table 6 Seven Factors Driving Growth
  • Table 7 Alternative Medicine Segments
  • Table 8 Six Factors Limiting Growth
  • Table 9 Seven Key Diagnostic Laboratory Technology Trends
  • Table 10 - Global Market by Region
  • Table 11 Global Market by Assay Type
  • Table 12 Global Market by Place
  • Table 13 Global Market by Product
  • Table 14 Chemistry by Country
  • Table 15 Microbiology by Country
  • Table 16 Hematology by Country
  • Table 17 Anatomic Pathology by Country
  • Table 18 Molecular Diagnostics by Country
  • Table 19 Esoteric by Country
  • Table 20 In Patient Hospital by Country
  • Table 21 Out Patient Hospital by Country
  • Table 22 Independent Laboratory by Country
  • Table 23 Physicians Office Laboratory by Country
  • Table 24 Other Laboratory by Country
  • Table 25 Instruments by Country
  • Table 26 Reagents by Country
  • Table 27 Labour by Country
  • Table 28 Overhead by Country
  • Table 29 Other Product by Country
  • Table 30 Clinical Lab Fee Schedule
  • Table 31 The Most Common Assays
  • Table 32 Largest Revenue Assays

Table of Figures

  • Figure 1 Global Healthcare Spending
  • Figure 2 The Road to Diagnostics
  • Figure 3 The Changing Age of The World's Population
  • Figure 4 Health Care Consumption by Age
  • Figure 5 Cancer Incidence - Age at Diagnosis
  • Figure 6 Centralized vs. Decentralized Laboratory Service
  • Figure 7 A Highly Multiplexed Syndromic Testing Unit
  • Figure 8 The Real Cost to Sequence the Human Genome
  • Figure 9 The Codevelopment Process
  • Figure 10 Comparing MDx Diagnostic and Traditional Testing
  • Figure 11 Global Market Pareto Chart
  • Figure 12 Global Market by Assay Type - Base vs. Final
  • Figure 13 Global Market by Assay Type Base Year
  • Figure 14 Global Market by Assay Type End Year
  • Figure 15 Assay Type Share by Year
  • Figure 16 Assay Type Segments Growth
  • Figure 17 Global Market by Place - Base vs. Final
  • Figure 18 Global Market by Place Base Year
  • Figure 19 Global Market by Place End Year
  • Figure 20 Place Share by Year
  • Figure 21 Place Segments Growth
  • Figure 22 Global Market by Product - Base vs. Final
  • Figure 23 Global Market by Product Base Year
  • Figure 24 Global Market by Product End Year
  • Figure 25 Product Share by Year
  • Figure 26 Product Segments Growth
  • Figure 27 Chemistry Growth
  • Figure 28 Microbiology Growth
  • Figure 29 Hematology Growth
  • Figure 30 Anatomic Pathology Growth
  • Figure 31 Molecular Diagnostics Growth
  • Figure 32 Esoteric Growth
  • Figure 33 In Patient Hospital Growth
  • Figure 34 Out Patient Hospital Growth
  • Figure 35 Independent Laboratory Growth
  • Figure 36 Physicians Office Laboratory Growth
  • Figure 37 Other Laboratory Growth
  • Figure 38 Instruments Growth
  • Figure 39 Reagents Growth
  • Figure 40 Labour Growth
  • Figure 41 Overhead Growth
  • Figure 42 Other Product Growth